Theratechnologies Inc. provided earnings guidance for the Fiscal year 2022. For the period, the company tightened to be in the range of $79 million - $82 million, or growth of the commercial portfolio to be in the range of 13% and 17%, as compared to the 2021 fiscal year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.09 CAD | -3.24% |
|
+3.98% | -2.34% |
07-10 | Theratechnologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2024 | CI |
07-10 | Transcript : Theratechnologies Inc., Q2 2024 Earnings Call, Jul 10, 2024 |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 70.21M | |
+8.54% | 100B | |
+11.97% | 43.89B | |
-11.76% | 33.24B | |
+79.66% | 29.36B | |
-12.20% | 16.08B | |
+4.00% | 14.68B | |
-1.90% | 12.87B | |
+178.17% | 10.55B | |
+5.24% | 8.83B |
- Stock Market
- Equities
- TH Stock
- News Theratechnologies Inc.
- Theratechnologies Inc. Provides Earnings Guidance for the Fiscal Year 2022